Adele G. MarthalerBenjamin SchmidAlisa TubsuwanUlla B. PoulsenPoul HyttelTroels T. NielsenJørgen E. NielsenBjørn HolstKøbenhavns UniversitetBioneer ASMahidol University2018-12-112019-03-142018-12-112019-03-142016-01-01Stem Cell Research. Vol.16, No.1 (2016), 199-20118767753187350612-s2.0-84955087885https://repository.li.mahidol.ac.th/handle/20.500.14594/43195© 2016. Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. Here, we demonstrate the generation of an induced pluripotent stem cell (iPSC) line of a SCA2 patient. The selected clone has been proven to be a bona fide iPSC line, which retains a normal karyotype. Due to its differentiation potential into neurons, this iPSC line will be a valuable tool in studying a disease-specific phenotype of SCA2.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyArticleSCOPUS10.1016/j.scr.2015.12.049